Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 3.2B | 3.5B | 2.3B | 4.0B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 149.5M | 123.0M | 191.4M | 151.3M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 31.8M | 27.1M | 23.2M | 23.8M |
Other income expense | 2.6M | 914K | 1.1M | 680K |
Pretax income | 1.3B | -70.8M | -83.1M | 1.7B |
Tax provision | 176.9M | -45.5M | -63.9M | 102.0M |
Net income | 1.2B | -25.3M | -19.2M | 1.6B |
Basic EPS | 17.3 | 3.3 | -4.0 | 22.7 |
Diluted EPS | 17.2 | 3.3 | -4.0 | 22.6 |
Basic average shares | 47.1M | 48.3M | 50.4M | 51.0M |
Diluted average shares | 47.3M | 48.5M | 50.4M | 51.1M |
EBITDA | — | — | — | — |
Net income from continuing op. | 1.2B | -25.3M | -19.2M | 1.6B |
Minority interests | -328.3M | 195.3M | -170.4M | -450.2M |
Preferred stock dividends | 13.3M | 2.4M | -2.6M | 17.9M |